2-(2-Butyl)-4-{4-[4-(4-methyloxy-phenyl)-piperazin-1-yl]-phenyl}-2,4-dihydro-[1,2,4]-triazol-3-one

itraconazole ep impurity a ; 2,4-dihydro-4-[[4-hydroxyphenyl]-1-piperazinyl] 98.50+% light gray powder ; 1-sec butyl-[4[4(4-methoxyphenyl)-1-piperazinyl]-phenyl]-1,2,4-triazolo-5-one ; 2-sec-butyl-4-(4-[4-(4-methyloxy-phenyl)-piperazin-1-yl]-phenyl)-2,4-dihydro-[1,2,4]-triazol-3-one ; phenyl]-2-(1-methylpropyl)-3h-1,2,4-triazol-3-one ; itraconazole impurity a ; 2-butan-2-yl-4-[4-[4-(4-methoxyphenyl)piperazin-1-yl]phenyl]-1,2,4-triazol-3-one ; 2,4-dihydro-4-[4-[4-(4-methoxyphenyl)-1-piperazinyl] ; 2,4-dihydro-4-[[4-hydroxyphenyl]-1-piperazinyl] ; 3h-1,2,4-triazol-3-one,2,4-dihydro-4-[4-[4-(4-methoxyphenyl)-1-